Paw Prosper expands US and Canada reach with exclusive Elvation VET Shockwave Therapy deal

Paw Prosper has deepened its alliance with Elvation Medical, gaining exclusive rights to distribute Elvation VET Shockwave Therapy in North America, enhancing its portfolio of non-invasive veterinary recovery solutions.

Paw Prosper has deepened its alliance with Elvation Medical, taking on exclusive commercial responsibility for Elvation VET Shockwave Therapy in the US and Canada, according to the companies. The agreement brings the PiezoWave2T VET into Paw Prosper’s rehabilitation range, alongside Respond Animal Therapeutics’ laser and pulsed electromagnetic field systems.

The device uses focused piezoelectric technology to deliver targeted shockwave treatment for ligament and tendon recovery in equine and small animal care. Elvation says the system is quiet, portable and adjustable, and in many cases avoids the need for sedation, features that may appeal to busy practices looking for flexible non-invasive options.

Paw Prosper said the move strengthens its position in veterinary rehabilitation and widens its clinical offering for both small animal and equine markets. The company also said several Elvation VET staff are joining its team, including product specialist Cindy Harrington, who will remain a key contact for clinics. That continuity should help maintain support, onboarding and product guidance as distribution shifts.

Elvation describes the partnership as a natural extension of its North American strategy, while Paw Prosper says the arrangement supports a broader portfolio-led approach to rehabilitation care. Veterinary customers can now obtain the system, accessories and clinical support directly through Paw Prosper.